816449-86-2 Usage
Uses
Used in Organic Synthesis:
(3-fluoro-5-hydroxymethyl-phenyl)acetic acid serves as a valuable intermediate in organic synthesis, facilitating the creation of a diverse range of chemical products. Its unique structure allows for further functionalization and modification, making it a versatile building block for the development of new compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (3-fluoro-5-hydroxymethyl-phenyl)acetic acid is utilized as a key component in drug discovery and development. Its specific functional groups and structural features can be exploited to design and synthesize novel pharmaceutical agents with potential therapeutic applications.
Used as a Building Block for Complex Molecules:
(3-fluoro-5-hydroxymethyl-phenyl)acetic acid also finds application as a fundamental building block in the synthesis of more complex organic molecules. Its presence in these molecules can influence their properties and reactivity, which is crucial for advancing the frontiers of chemical research and innovation.
It is essential to exercise caution and adhere to safety guidelines when handling (3-fluoro-5-hydroxymethyl-phenyl)acetic acid in a laboratory environment to ensure the safety of researchers and the integrity of experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 816449-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,4 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 816449-86:
(8*8)+(7*1)+(6*6)+(5*4)+(4*4)+(3*9)+(2*8)+(1*6)=192
192 % 10 = 2
So 816449-86-2 is a valid CAS Registry Number.
816449-86-2Relevant academic research and scientific papers
TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page 131, (2010/02/10)
The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.
